CELZ · Creative Medical Technology Holdings Inc
United States · RS rating 22 · As of 2026-11-03
| Price | 0.67 USD |
|---|---|
| 1-day change | +8.0% |
| RS rating (overall / 1M / 3M / 12M) | 22 / 15 / 68 / 9 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 20 / 8 / 33 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -7.9% |
| Sales growth Q/Q | -100.0% |
| Distance from 52-week high | +79.5% |
| Market cap (USD) | $8.3M |